{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:29:11Z","timestamp":1760707751139},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00508-006-0684-0","type":"journal-article","created":{"date-parts":[[2006,11,27]],"date-time":"2006-11-27T18:07:10Z","timestamp":1164650830000},"page":"50-57","source":"Crossref","is-referenced-by-count":8,"title":["Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes","Immunstimulierende rekonstituierte Influenza-Virosomen als Vehikel f\u00fcr optimierte Malaria-Antigene"],"prefix":"10.1007","volume":"118","author":[{"given":"Nicole","family":"Westerfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Pluschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinaldo","family":"Zurbriggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"2","key":"684_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/156652406776055221","volume":"6","author":"L Schofield","year":"2006","unstructured":"Schofield L, Mueller I (2006) Clinical immunity to malaria. Curr Mol Med 6 (2): 205\u2013221","journal-title":"Curr Mol Med"},{"issue":"4","key":"684_CR2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/infdis\/172.4.1047","volume":"172","author":"C Beadle","year":"1995","unstructured":"Beadle C, McElroy PD, Oster CN, Beier JC, Oloo AJ, Onyango FK, et al (1995) Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design. J Infect Dis 172 (4): 1047\u20131054","journal-title":"J Infect Dis"},{"key":"684_CR3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","volume":"192","author":"S Cohen","year":"1961","unstructured":"Cohen S, McGregor IA, Carrington S (1961) Gammaglobulin and acquired immunity to human malaria. Nature 192: 733\u2013737","journal-title":"Nature"},{"issue":"8026","key":"684_CR4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(77)92551-X","volume":"1","author":"GH Mitchell","year":"1977","unstructured":"Mitchell GH, Richards WH, Butcher GA, Cohen S (1977) Merozoite vaccination of douroucouli monkeys against falciparum malaria. Lancet 1 (8026): 1335\u20131338","journal-title":"Lancet"},{"issue":"2","key":"684_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0074-02762001000200014","volume":"96","author":"J Oliveira-Ferreira","year":"2001","unstructured":"Oliveira-Ferreira J, Daniel-Ribeiro C (2001) Protective CD8+ T cell responses against the pre-erythrocytic stages of malaria parasites: an overview. Mem Inst Oswaldo Cruz 96 (2): 221\u2013227","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"7","key":"684_CR6","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.159.7.3400","volume":"159","author":"C Hirunpetcharat","year":"1997","unstructured":"Hirunpetcharat C, Tian JH, Kaslow DC, van Rooijen N, Kumar S, Berzofsky JA, et al (1997) Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J Immunol 159 (7): 3400\u20133411","journal-title":"J Immunol"},{"issue":"8026","key":"684_CR7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(77)92551-X","volume":"1","author":"GH Mitchell","year":"1977","unstructured":"Mitchell GH, Richards WH, Butcher GA, Cohen S (1977) Merozoite vaccination of douroucouli monkeys against falciparum malaria. Lancet 1 (8026): 1335\u20131338","journal-title":"Lancet"},{"issue":"7022","key":"684_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature03188","volume":"433","author":"AK Mueller","year":"2005","unstructured":"Mueller AK, Labaied M, Kappe SH, Matuschewski K (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433 (7022): 164\u2013167","journal-title":"Nature"},{"issue":"3","key":"684_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","volume":"266","author":"DF Clyde","year":"1973","unstructured":"Clyde DF, Most H, McCarthy VC, Vanderberg JP (1973) Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 266 (3): 169\u2013177","journal-title":"Am J Med Sci"},{"issue":"3","key":"684_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4269\/ajtmh.1975.24.397","volume":"24","author":"DF Clyde","year":"1975","unstructured":"Clyde DF (1975) Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 24 (3): 397\u2013401","journal-title":"Am J Trop Med Hyg"},{"issue":"9443","key":"684_CR11","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","volume":"364","author":"PL Alonso","year":"2004","unstructured":"Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, et al (2004) Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364 (9443): 1411\u20131420","journal-title":"Lancet"},{"issue":"9297","key":"684_CR12","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(01)06957-4","volume":"358","author":"KA Bojang","year":"2001","unstructured":"Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A, Kester KE, et al (2001) Efficacy of RTS,S\/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358 (9297): 1927\u20131934","journal-title":"Lancet"},{"issue":"2","key":"684_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","volume":"336","author":"JA Stoute","year":"1997","unstructured":"Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, et al (1997) A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med 336 (2): 86\u201391","journal-title":"N Engl J Med"},{"issue":"11","key":"684_CR14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pt.2005.08.018","volume":"21","author":"GA Targett","year":"2005","unstructured":"Targett GA (2005) Malaria vaccines 1985\u20132005: a full circle? Trends Parasitol 21 (11): 499\u2013503","journal-title":"Trends Parasitol"},{"issue":"4","key":"684_CR15","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1128\/IAI.69.4.2558-2568.2001","volume":"69","author":"R Moreno","year":"2001","unstructured":"Moreno R, Poltl-Frank F, Stuber D, Matile H, Mutz M, Weiss NA, et al (2001) Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro. Infect Immun 69 (4): 2558\u20132568","journal-title":"Infect Immun"},{"issue":"9","key":"684_CR16","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/IAI.70.9.5328-5331.2002","volume":"70","author":"RI Nwuba","year":"2002","unstructured":"Nwuba RI, Sodeinde O, Anumudu CI, Omosun YO, Odaibo AB, Holder AA, et al (2002) The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies. Infect Immun 70 (9): 5328\u20135331","journal-title":"Infect Immun"},{"issue":"10","key":"684_CR17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.186.10.1689","volume":"186","author":"JA Guevara Patino","year":"1997","unstructured":"Guevara Patino JA, Holder AA, McBride JS, Blackman MJ (1997) Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J Exp Med 186 (10): 1689\u20131699","journal-title":"J Exp Med"},{"issue":"5","key":"684_CR18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1006\/jmbi.2001.4574","volume":"307","author":"C Uthaipibull","year":"2001","unstructured":"Uthaipibull C, Aufiero B, Syed SE, Hansen B, Guevara Patino JA, Angov E, et al (2001) Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J Mol Biol 307 (5): 1381\u20131394","journal-title":"J Mol Biol"},{"issue":"2","key":"684_CR19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/IAI.63.2.456-466.1995","volume":"63","author":"AF Egan","year":"1995","unstructured":"Egan AF, Chappel JA, Burghaus PA, Morris JS, McBride JS, Holder AA, et al (1995) Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1 (19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect Immun 63 (2): 456\u2013466","journal-title":"Infect Immun"},{"issue":"5","key":"684_CR20","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/IAI.67.5.2193-2200.1999","volume":"67","author":"L Wang","year":"1999","unstructured":"Wang L, Black CG, Marshall VM, Coppel RL (1999) Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum. Infect Immun 67 (5): 2193\u20132200","journal-title":"Infect Immun"},{"key":"684_CR21","volume-title":"Concepts in vaccine development","author":"H Schild","year":"1996","unstructured":"Schild H, Rammensee HR (1996) Peptide based vaccines. In: Kaufmann SHE (ed) Concepts in vaccine development. Walter de Gruyter, Berlin"},{"issue":"12","key":"684_CR22","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nbt1197-1280","volume":"15","author":"SC Gilbert","year":"1997","unstructured":"Gilbert SC, Plebanski M, Harris SJ, Allsopp CE, Thomas R, Layton GT, et al (1997) A protein particle vaccine containing multiple malaria epitopes. Nat Biotechnol 15 (12): 1280\u20131284","journal-title":"Nat Biotechnol"},{"issue":"8","key":"684_CR23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0169-4758(97)01091-0","volume":"13","author":"SC Gilbert","year":"1997","unstructured":"Gilbert SC, Hill AV (1997) Protein particle vaccines against malaria. Parasitol Today 13 (8): 302\u2013306","journal-title":"Parasitol Today"},{"issue":"12","key":"684_CR24","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1128\/IAI.70.12.6860-6870.2002","volume":"70","author":"A Birkett","year":"2002","unstructured":"Birkett A, Lyons K, Schmidt A, Boyd D, Oliveira GA, Siddique A, et al (2002) A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect Immun 70 (12): 6860\u20136870","journal-title":"Infect Immun"},{"issue":"12","key":"684_CR25","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nbt1197-1280","volume":"15","author":"SC Gilbert","year":"1997","unstructured":"Gilbert SC, Plebanski M, Harris SJ, Allsopp CE, Thomas R, Layton GT, et al (1997) A protein particle vaccine containing multiple malaria epitopes. Nat Biotechnol 15 (12): 1280\u20131284","journal-title":"Nat Biotechnol"},{"issue":"28","key":"684_CR26","doi-asserted-by":"crossref","first-page":"20225","DOI":"10.1016\/S0021-9258(19)88690-8","volume":"267","author":"M Tsurudome","year":"1992","unstructured":"Tsurudome M, Gluck R, Graf R, Falchetto R, Schaller U, Brunner J (1992) Lipid interactions of the hemagglutinin HA2 NH2-terminal segment during influenza virus-induced membrane fusion. J Biol Chem 267 (28): 20225\u201320232","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"684_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0304-4157(00)00006-X","volume":"1508","author":"M Ollivon","year":"2000","unstructured":"Ollivon M, Lesieur S, Grabielle-Madelmont C, Paternostre M (2000) Vesicle reconstitution from lipid-detergent mixed micelles. Biochim Biophys Acta 1508 (1\u20132): 34\u201350","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"684_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0163-7827(99)00017-X","volume":"39","author":"R Zurbriggen","year":"2000","unstructured":"Zurbriggen R, Novak-Hofer I, Seelig A, Gluck R (2000) IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization. Prog Lipid Res 39 (1): 3\u201318","journal-title":"Prog Lipid Res"},{"issue":"6","key":"684_CR29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/intimm\/dxh249","volume":"17","author":"M Amacker","year":"2005","unstructured":"Amacker M, Engler O, Kammer AR, Vadrucci S, Oberholzer D, Cerny A, et al (2005) Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells. Int Immunol 17 (6): 695\u2013704","journal-title":"Int Immunol"},{"issue":"6","key":"684_CR30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/intimm\/dxf026","volume":"14","author":"IP Hunziker","year":"2002","unstructured":"Hunziker IP, Grabscheid B, Zurbriggen R, Gluck R, Pichler WJ, Cerny A (2002) In vitro studies of core peptidebearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus. Int Immunol 14 (6): 615\u2013626","journal-title":"Int Immunol"},{"issue":"3","key":"684_CR31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","volume":"266","author":"DF Clyde","year":"1973","unstructured":"Clyde DF, Most H, McCarthy VC, Vanderberg JP (1973) Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 266 (3): 169\u2013177","journal-title":"Am J Med Sci"},{"issue":"2","key":"684_CR32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4269\/ajtmh.1993.49.166","volume":"49","author":"JE Egan","year":"1993","unstructured":"Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, Grau GE, et al (1993) Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg 49 (2): 166\u2013173","journal-title":"Am J Trop Med Hyg"},{"key":"684_CR33","first-page":"15","volume-title":"Malaria vaccine development","author":"P Sinnis","year":"1996","unstructured":"Sinnis P, Nussenzweig V (1996) Preventing sporozoite invasion of hepatocytes. In: Hoffman SL (ed) Malaria vaccine development. American Society for Microbiology, Washington DC, pp 15\u201333"},{"issue":"5","key":"684_CR34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4269\/ajtmh.1991.45.539","volume":"45","author":"D Herrington","year":"1991","unstructured":"Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, et al (1991) Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg 45 (5): 539\u2013547","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 3","key":"684_CR35","doi-asserted-by":"crossref","first-page":"S579","DOI":"10.1093\/clinids\/11.Supplement_3.S579","volume":"11","author":"RS Nussenzweig","year":"1989","unstructured":"Nussenzweig RS, Nussenzweig V (1989) Antisporozoite vaccine for malaria: experimental basis and current status. Rev Infect Dis 11 [Suppl 3]: S579\u2013S585","journal-title":"Rev Infect Dis"},{"issue":"4","key":"684_CR36","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.135.4.2790","volume":"135","author":"F Zavala","year":"1985","unstructured":"Zavala F, Masuda A, Graves PM, Nussenzweig V, Nussenzweig RS (1985) Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J Immunol 135 (4): 2790\u20132793","journal-title":"J Immunol"},{"issue":"6127","key":"684_CR37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/328257a0","volume":"328","author":"DA Herrington","year":"1987","unstructured":"Herrington DA, Clyde DF, Losonsky G, Cortesia M, Murphy JR, Davis J, et al (1987) Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328 (6127): 257\u2013259","journal-title":"Nature"},{"issue":"11","key":"684_CR38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/1439-7633(20011105)2:11<838::AID-CBIC838>3.0.CO;2-4","volume":"2","author":"R Moreno","year":"2001","unstructured":"Moreno R, Jiang L, Moehle K, Zurbriggen R, Gluck R, Robinson JA, et al (2001) Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design. Chembiochem 2 (11): 838\u2013843","journal-title":"Chembiochem"},{"issue":"21","key":"684_CR39","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/anie.200250348","volume":"42","author":"B Pfeiffer","year":"2003","unstructured":"Pfeiffer B, Peduzzi E, Moehle K, Zurbriggen R, Gluck R, Pluschke G, et al (2003) A virosome-mimotope approach to synthetic vaccine design and optimization: synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate. Angew Chem Int Ed Engl 42 (21): 2368\u20132371","journal-title":"Angew Chem Int Ed Engl"},{"issue":"Pt 21","key":"684_CR40","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1242\/jeb.00646","volume":"206","author":"S Mahanty","year":"2003","unstructured":"Mahanty S, Saul A, Miller LH (2003) Progress in the development of recombinant and synthetic blood-stage malaria vaccines. J Exp Biol 206 (Pt 21): 3781\u20133788","journal-title":"J Exp Biol"},{"issue":"5","key":"684_CR41","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","volume":"69","author":"AN Hodder","year":"2001","unstructured":"Hodder AN, Crewther PE, Anders RF (2001) Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun 69 (5): 3286\u20133294","journal-title":"Infect Immun"},{"issue":"2","key":"684_CR42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-6851(00)00250-4","volume":"109","author":"CH Kocken","year":"2000","unstructured":"Kocken CH, Narum1 DL, Massougbodji A, Ayivi B, Dubbeld MA, van der WA, et al (2000) Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol Biochem Parasitol 109 (2): 147\u2013156","journal-title":"Mol Biochem Parasitol"},{"issue":"2\u20133","key":"684_CR43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0264-410X(97)88331-4","volume":"16","author":"RF Anders","year":"1998","unstructured":"Anders RF, Crewther PE, Edwards S, Margetts M, Matthew ML, Pollock B, et al (1998) Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16 (2\u20133): 240\u2013247","journal-title":"Vaccine"},{"issue":"33","key":"684_CR44","doi-asserted-by":"crossref","first-page":"31311","DOI":"10.1074\/jbc.M103076200","volume":"276","author":"SA Howell","year":"2001","unstructured":"Howell SA, Withers-Martinez C, Kocken CH, Thomas AW, Blackman MJ (2001) Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem 276 (33): 31311\u201331320","journal-title":"J Biol Chem"},{"issue":"4","key":"684_CR45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0022-2836(02)00806-9","volume":"322","author":"M Nair","year":"2002","unstructured":"Nair M, Hinds MG, Coley AM, Hodder AN, Foley M, Anders RF, et al (2002) Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). J Mol Biol 322 (4): 741\u2013753","journal-title":"J Mol Biol"},{"issue":"46","key":"684_CR46","doi-asserted-by":"crossref","first-page":"29446","DOI":"10.1074\/jbc.271.46.29446","volume":"271","author":"AN Hodder","year":"1996","unstructured":"Hodder AN, Crewther PE, Matthew ML, Reid GE, Moritz RL, Simpson RJ, et al (1996) The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 271 (46): 29446\u201329452","journal-title":"J Biol Chem"},{"issue":"8","key":"684_CR47","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1128\/IAI.71.8.4749-4758.2003","volume":"71","author":"MS Mueller","year":"2003","unstructured":"Mueller MS, Renard A, Boato F, Vogel D, Naegeli M, Zurbriggen R, et al (2003) Induction of parasite growthinhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1. Infect Immun 71 (8): 4749\u20134758","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"684_CR48","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0264-410X(98)00361-2","volume":"17","author":"R Zurbriggen","year":"1999","unstructured":"Zurbriggen R, Gluck R (1999) Immunogenicity of IRIV-versus alum-adjuvanted diphtheria an tetanus toxoid vaccnes in influenza primed mice. Vaccine 17 (11\u201312): 1301\u20131305","journal-title":"Vaccine"},{"issue":"11\u201312","key":"684_CR49","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0264-410X(98)00361-2","volume":"17","author":"R Zurbriggen","year":"1999","unstructured":"Zurbriggen R, Gluck R (1999) Immunogenicity of IRIV-versus alum-adjuvanted diphtheria an tetanus toxoid vaccnes in influenza primed mice. Vaccine 17 (11\u201312): 1301\u20131305","journal-title":"Vaccine"},{"issue":"3","key":"684_CR50","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2249.1999.00989.x","volume":"117","author":"F Poltl-Frank","year":"1999","unstructured":"Poltl-Frank F, Zurbriggen R, Helg A, Stuart F, Robinson J, Gluck R, et al (1999) Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine. Clin Exp Immunol 117 (3): 496\u2013503","journal-title":"Clin Exp Immunol"},{"issue":"6127","key":"684_CR51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/328257a0","volume":"328","author":"DA Herrington","year":"1987","unstructured":"Herrington DA, Clyde DF, Losonsky G, Cortesia M, Murphy JR, Davis J, et al (1987) Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328 (6127): 257\u2013259","journal-title":"Nature"},{"issue":"1\u20132","key":"684_CR52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-3024.2006.00767.x","volume":"28","author":"R Stephens","year":"2006","unstructured":"Stephens R, Langhorne J (2006) Priming of CD4+ T cells and development of CD4+ T cell memory; lessons for malaria. Parasite Immunol 28 (1\u20132): 25\u201330","journal-title":"Parasite Immunol"},{"issue":"Suppl","key":"684_CR53","first-page":"13","volume":"68","author":"KH Rieckmann","year":"1990","unstructured":"Rieckmann KH (1990) Human immunization with attenuated sporozoites. Bull World Health Organ 68 [Suppl]: 13\u201316","journal-title":"Bull World Health Organ"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-006-0684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-006-0684-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-006-0684-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T20:53:48Z","timestamp":1683665628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-006-0684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":53,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1007\/s00508-006-0684-0","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}